Clinical Trial Update: A Study of ABTL0812 in Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

The ABTL0812 pancreatic cancer trial (Phase 1/Phase 2) is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ABTL0812

Snippet

Sponsor: Ability Pharmaceuticals SL | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: SUSPENDED